Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1978 1
1979 1
1980 1
1981 1
1983 1
1984 2
1985 1
1986 2
1987 3
1988 2
1989 3
1990 3
1991 3
1992 8
1993 15
1994 14
1995 7
1996 13
1997 8
1998 17
1999 13
2000 16
2001 20
2002 16
2003 18
2004 18
2005 23
2006 44
2007 30
2008 45
2009 28
2010 32
2011 35
2012 24
2013 18
2014 18
2015 25
2016 21
2017 23
2018 30
2019 40
2020 42
2021 26
2022 15
2023 12
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

659 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Atypical hyperplasia of breast"
Page 1
Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
Elfgen C, Leo C, Kubik-Huch RA, Muenst S, Schmidt N, Quinn C, McNally S, van Diest PJ, Mann RM, Bago-Horvath Z, Bernathova M, Regitnig P, Fuchsjäger M, Schwegler-Guggemos D, Maranta M, Zehbe S, Tausch C, Güth U, Fallenberg EM, Schrading S, Kothari A, Sonnenschein M, Kampmann G, Kulka J, Tille JC, Körner M, Decker T, Lax SF, Daniaux M, Bjelic-Radisic V, Kacerovsky-Strobl S, Condorelli R, Gnant M, Varga Z. Elfgen C, et al. Virchows Arch. 2023 Jul;483(1):5-20. doi: 10.1007/s00428-023-03566-x. Epub 2023 Jun 17. Virchows Arch. 2023. PMID: 37330436 Free PMC article. Review.
The heterogeneous group of B3 lesions in the breast harbors lesions with different malignant potential and progression risk. As several studies about B3 lesions have been published since the last Consensus in 2018, the 3rd International Consensus Conference discussed the s …
The heterogeneous group of B3 lesions in the breast harbors lesions with different malignant potential and progression risk. As sever …
Noninvasive papillary proliferations.
Oyama T, Koerner FC. Oyama T, et al. Semin Diagn Pathol. 2004 Feb;21(1):32-41. doi: 10.1053/j.semdp.2003.10.011. Semin Diagn Pathol. 2004. PMID: 15074557 Review.
Proliferations within the stalk of a papilloma require especially careful attention; one must observe large masses of cells demonstrating both cytological and architectural atypicality and devoid of intervening stroma to make the diagnosis of low-grade ductal carcin …
Proliferations within the stalk of a papilloma require especially careful attention; one must observe large masses of cells demonstra …
Reassessing risk models for atypical hyperplasia: age may not matter.
Mazzola E, Coopey SB, Griffin M, Polubriaginof F, Buckley JM, Parmigiani G, Garber JE, Smith BL, Gadd MA, Specht MC, Guidi A, Hughes KS. Mazzola E, et al. Breast Cancer Res Treat. 2017 Sep;165(2):285-291. doi: 10.1007/s10549-017-4320-7. Epub 2017 Jun 6. Breast Cancer Res Treat. 2017. PMID: 28589368 Free PMC article. Review.
PURPOSE: The aim of this study was to investigate the influence of age at diagnosis of atypical hyperplasia ("atypia", ductal [ADH], lobular [ALH], or severe ADH) on the risk of developing subsequent invasive breast cancer or ductal carcinoma in situ (DCIS). …
PURPOSE: The aim of this study was to investigate the influence of age at diagnosis of atypical hyperplasia ("atypia", ductal …
Effective Surveillance of High-Risk Women.
Lotz M, Ghebremichael M, Chervinsky K, Zorc T, Brenner C, Bousvaros G, Pories SE. Lotz M, et al. Clin Breast Cancer. 2022 Apr;22(3):e263-e269. doi: 10.1016/j.clbc.2021.07.014. Epub 2021 Jul 27. Clin Breast Cancer. 2022. PMID: 34429241
BACKGROUND: This study addresses the effectiveness of risk models and screening breast magnetic resonance imaging (MRI) in women who have atypical hyperplasia (AH), lobular carcinoma in situ (LCIS), or a family history of breast cancer, but not a genet …
BACKGROUND: This study addresses the effectiveness of risk models and screening breast magnetic resonance imaging (MRI) in women who …
An update on the management of breast atypical ductal hyperplasia.
Schiaffino S, Cozzi A, Sardanelli F. Schiaffino S, et al. Br J Radiol. 2020 Jun;93(1110):20200117. doi: 10.1259/bjr.20200117. Epub 2020 Apr 1. Br J Radiol. 2020. PMID: 32207989 Free PMC article.
Among lesions with uncertain malignant potential found at percutaneous breast biopsy, atypical ductal hyperplasia (ADH) carries both the highest risk of underestimation and the closest and most pathologist-dependent differential diagnosis with ductal carcinom …
Among lesions with uncertain malignant potential found at percutaneous breast biopsy, atypical ductal hyperplasia (ADH) …
B3 lesions of the breast and cancer risk. A single-centre experience.
Marino G, Accardo G, Thodas A, Botte M, Di Nardo G, Calice G, Patitucci G, Di Cerbo A, La Torre G. Marino G, et al. Ann Ital Chir. 2023;94:226-230. Ann Ital Chir. 2023. PMID: 37530037
METHODS: Between January 2018 and December 2021, 83 patients undergoing ultrasound guided tru-cut needle biopsy or VABB with a B3 diagnosis and surgical excision following multidisciplinary discussion were retrospectively reviewed in our Breast Unit. RESULTS: Out of a tota …
METHODS: Between January 2018 and December 2021, 83 patients undergoing ultrasound guided tru-cut needle biopsy or VABB with a B3 diagnosis …
Breast Hyperplasias, Risk Signature, and Breast Cancer.
Poola I, Yue Q, Gillespie JW, Sullivan PS, Aguilar-Jakthong J, Rao J, Shaaban AM, Sauter ER, Ricci AJ. Poola I, et al. Cancer Prev Res (Phila). 2019 Jul;12(7):471-480. doi: 10.1158/1940-6207.CAPR-19-0051. Epub 2019 Jun 25. Cancer Prev Res (Phila). 2019. PMID: 31239263
We assayed the markers by IHC and combined their expression levels to obtain a composite value from 0-10, which we called a "Cancer Risk Score." We demonstrate that the four marker-based risk scores predict subsequent cancer development with an accuracy of 91 …
We assayed the markers by IHC and combined their expression levels to obtain a composite value from 0-10, which we called a "Cancer Risk …
Management of Lobular Neoplasia Diagnosed by Core Biopsy.
Jani C, Lotz M, Keates S, Gupta Y, Walker A, Al Omari O, Parvez A, Patel D, Gnata M, Perry J, Khorashadi L, Weissmann L, Pories SE. Jani C, et al. Breast J. 2023 Apr 18;2023:8185446. doi: 10.1155/2023/8185446. eCollection 2023. Breast J. 2023. PMID: 37114120 Free PMC article.
Lobular neoplasia (LN) involves proliferative changes within the breast lobules. LN is divided into lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH). ...We reviewed the data of breast biopsies conducted at our hospital over this …
Lobular neoplasia (LN) involves proliferative changes within the breast lobules. LN is divided into lobular carcinoma in situ (LCIS) …
Gene expression signature of atypical breast hyperplasia and regulation by SFRP1.
Gregory KJ, Roberts AL, Conlon EM, Mayfield JA, Hagen MJ, Crisi GM, Bentley BA, Kane JJ, Makari-Judson G, Mason HS, Yu J, Zhu LJ, Simin K, Johnson JPS, Khan A, Schneider BR, Schneider SS, Jerry DJ. Gregory KJ, et al. Breast Cancer Res. 2019 Jun 27;21(1):76. doi: 10.1186/s13058-019-1157-5. Breast Cancer Res. 2019. PMID: 31248446 Free PMC article.
BACKGROUND: Atypical breast hyperplasias (AH) have a 10-year risk of progression to invasive cancer estimated at 4-7%, with the overall risk of developing breast cancer increased by ~ 4-fold. ...Knockdown of SFRP1 in 76N-Tert cells resulted altered exp …
BACKGROUND: Atypical breast hyperplasias (AH) have a 10-year risk of progression to invasive cancer estimated at 4-7%, …
Borderline breast lesions: diagnostic challenges and clinical implications.
Masood S, Rosa M. Masood S, et al. Adv Anat Pathol. 2011 May;18(3):190-8. doi: 10.1097/PAP.0b013e31821698cc. Adv Anat Pathol. 2011. PMID: 21490436 Review.
Breast cancer remains a global public health problem and is currently the most polarized cancer in the world. Attention to this disease, public awareness, and advances in breast imaging have made a positive impact on breast cancer screening and detection. ...
Breast cancer remains a global public health problem and is currently the most polarized cancer in the world. Attention to this disea …
659 results